Phathom Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Phathom Pharmaceuticals Inc
TickerPHAT
CIK #0001783183
CUSIP71722W107
SectorLife Sciences - Pharmaceutical Preparations
Address2150 E Lake Cook Road, Suite 800, Buffalo Grove, IL 60089
Source [EDGAR]
CIK Filing 2011 - 2026
[0001783183] 10-K
[0001783183] 10-Q
[0001783183] 3
[0001783183] 4
[0001783183] 5
[0001783183] 8-K
[0001783183] SC 13D
[0001783183] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Millennium Management LLC Phathom Pharmaceuticals Inc [2026-03-12] 0.0
Millennium Management LLC Phathom Pharmaceuticals Inc [2025-08-13] 0.0
BlackRock Inc Phathom Pharmaceuticals Inc [2024-11-12] 5.2
Prudential Financial Inc Phathom Pharmaceuticals Inc [2024-11-05] 0.0
Jennison Associates LLC Phathom Pharmaceuticals Inc [2024-11-04] 10.4
BlackRock Inc Phathom Pharmaceuticals Inc [2024-10-21] 5.2
Carlyle Group Inc Phathom Pharmaceuticals Inc [2023-03-09] 6.7
Flynn James E Phathom Pharmaceuticals Inc [2022-09-23] 5.81
Avidity Partners Management LP Phathom Pharmaceuticals Inc [2022-02-14] 6.0
Vanguard Group Inc Phathom Pharmaceuticals Inc [2022-02-10] 6.14
Janus Henderson Group PLC Phathom Pharmaceuticals Inc [2020-02-14] 6.0
Invesco Ltd Phathom Pharmaceuticals Inc [2020-02-13] 8.6
Medicxi Growth I LP Phathom Pharmaceuticals Inc [2020-02-10] 8.2
Yamada Tadataka Phathom Pharmaceuticals Inc [2020-02-10] 6.9
Socks David A Phathom Pharmaceuticals Inc [2020-02-10] 6.9
RA Capital Management LP Phathom Pharmaceuticals Inc [2019-11-08] 12.6
Frazier Life Sciences IX LP Phathom Pharmaceuticals Inc [2019-11-06] 25.1
Takeda Pharmaceutical Co Ltd Phathom Pharmaceuticals Inc [2019-11-06] 24.7
Form 3/4/5 Filer 2011 - 2026
Phathom Pharmaceuticals Inc
Parikh Asit
Topper James N
Stenhouse Mark
Fields Heidi
Cola Michael F
Schroeder Theodore R
Karbe Frank
Breedlove Robert Charles
Basta Steven L
Cook Anne Marie
Narula Sanjeev
Henderson Molly
Curran Terrie
Nabulsi Azmi
Socks David A
Medicxi Growth I GP Ltd
Medicxi Growth I LP
Medicxi IV LP
Medicxi Co-Invest IV LP
Medicxi Ventures Management Jersey Limited
Medicxi IV GP Ltd
Medicxi Growth Co-Invest I LP
Takeda Pharmaceutical Co Ltd
Guzzo Anthony J
Yamada Tadataka
Shah Rajeev M
RA Capital Healthcare Fund LP
RA Capital Management LP
Kolchinsky Peter
Branning Todd P
Heron Patrick J
Frazier Life Sciences IX LP
Fhmls IX LLC
Fhmls IX LP
Edwards Jonathan S
Slavinsky Christopher W
Kohli Aditya
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Parikh Asit
Common Stock
2026-03-10 Gift 40,000 $0.00
Parikh Asit
Common Stock
2026-03-10 Gift 40,000 $0.00
Breedlove Robert Charles
Common Stock
2026-02-27 Tax withheld 414 $12.56 5,200
Breedlove Robert Charles
Common Stock
2026-02-27 Grant 2,790 $0.00
Breedlove Robert Charles
Common Stock
2026-02-27 Tax withheld 964 $12.56 12,108
Breedlove Robert Charles
Common Stock
2026-02-27 Grant 13,000 $0.00
Cook Anne Marie
Common Stock
2026-02-10 Tax withheld 1,535 $12.82 19,679
Basta Steven L
Common Stock
2026-02-10 Grant 12,362 $0.00
Basta Steven L
Common Stock
2026-02-10 Tax withheld 6,277 $12.82 80,471
Cook Anne Marie
Common Stock
2026-02-10 Grant 3,461 $0.00
Parikh Asit
Common Stock
2026-01-23 Gift 80,500 $0.00
Parikh Asit
Common Stock
2026-01-23 Gift 80,500 $0.00
Breedlove Robert Charles
Common Stock
2026-01-21 Tax withheld 776 $13.61 10,561
Parikh Asit
Common Stock (Right to Buy) · derivative
2026-01-13 Option exercise 8,750 $0.00
Parikh Asit
Common Stock
2026-01-13 Option exercise 8,750 $10.30 90,125
Cook Anne Marie
Common Stock
2026-01-02 Grant 75,345 $0.00
Narula Sanjeev
Common Stock
2026-01-02 Grant 82,715 $0.00
Basta Steven L
Common Stock
2026-01-02 Grant 251,034 $0.00
Basta Steven L
Stock Option (Right to Buy) · derivative
2026-01-02 Grant 226,156 $0.00
Cook Anne Marie
Stock Option (Right to Buy) · derivative
2026-01-02 Grant 67,878 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 176 68,825,668
2025-12-31 174 61,570,624
2025-09-30 134 62,447,565
2025-06-30 120 58,859,118
2025-03-31 139 63,040,441
2024-12-31 145 66,262,717
2024-09-30 134 71,717,555
2024-06-30 116 58,139,607
2024-03-31 116 55,535,405
2023-12-31 119 53,855,720
2023-09-30 112 43,216,018
2023-06-30 104 42,378,589
Form 13F Holdings
Firm Period DFND Voting Shares
Wasatch Advisors LP [2026-06-30] SOLE 1,307,247 1,307,247
Hennion & Walsh Asset Management Inc [2026-06-30] SOLE 327,278 327,278
Simplify Asset Management Inc [2026-06-30] SOLE 249,267 249,267
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 39,845 39,845
Summit Financial Wealth Advisors LLC [2026-06-30] SOLE 0 22,143
Inspirion Wealth Advisors LLC [2026-06-30] SOLE 0 19,914
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 0 18,731
MassMutual Private Wealth & Trust FSB [2026-06-30] SOLE 427 427
Gamma Investing LLC [2026-06-30] DFND 400 400
Farther Finance Advisors LLC [2026-06-30] SOLE 0 342
True Wealth Design LLC [2026-06-30] SOLE 0 88
Elevation Wealth Partners LLC [2026-06-30] SOLE 0 20
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com